Ranger Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.1M | Buy |
300,025
+109,935
| +58% | +$12.5M | 2.38% | 9 |
|
|
2025
Q1 | $20M | Buy |
190,090
+107,885
| +131% | +$11.3M | 1.43% | 31 |
|
|
2024
Q4 | $8.81M | Sell |
82,205
-1,760
| -2% | -$189K | 0.56% | 53 |
|
|
2024
Q3 | $8.4M | Buy |
83,965
+15,570
| +23% | +$1.56M | 0.54% | 54 |
|
|
2024
Q2 | $5.76M | Buy |
68,395
+16,945
| +33% | +$1.43M | 0.39% | 62 |
|
|
2024
Q1 | $3.76M | Buy |
+51,450
| New | +$3.76M | 0.24% | 70 |
|